JK
Jeffrey B Kindler
Director

Jeffrey B Kindler insider trades: Precigen (PGEN) stock buys and sales

Director, Precigen Last trade Aug 26, 2026 217 Form 4 filings
$2.2M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2005
10
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jeffrey reports to the SEC

and 4 more companies

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 26, 2026PGEN↓ Sell$1.4M
Dec 12, 2025PGEN↓ Sell$856K
Sep 30, 2025PGEN↓ Sell$604K
Dec 9, 2024PRGO↓ Sell$497K
Dec 28, 2023PGEN↓ Sell$136K
Aug 11, 2022PGEN↓ Sell$115K
Feb 10, 2020PPD↑ Buy$500K
Aug 11, 2017XON↑ Buy$100K
Apr 22, 2014CMG↑ Buy$510K
Aug 13, 2013XON↑ Buy$528K
May 13, 2005PFE↓ Sell$387K
May 10, 2005PFE↓ Sell$166K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PGEN insiders

Open-market trades in the last 12 months

About Jeffrey B Kindler's insider trades

Jeffrey B Kindler is a director at Precigen (PGEN). Since May 10, 2005, Jeffrey has reported 4 open-market purchases worth $1.6M and 8 sales worth $4.1M on SEC Form 4. In the last 12 months: 2 sales ($2.2M).

Their filings also include grants and awards (178 filings), option exercises (28 filings), shares withheld for taxes (14 filings), gifts (6 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PGEN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.